Max S. Topp, MD^1*, Monica Tani^2*, Michael Dickinson, MBBS, D. Med Sci, FRACP, FRCPA³, Nilanjan Ghosh, MD, PhD⁴, Armando Santoro, MD^5*, Antonio Pinto, MD^6*, Francesc Bosch, MD PhD^7*, Christopher P. Fox, MD, PhD⁸, Armando Lopez-Guillermo, MD PhD⁹, Thomas Gastinne, MD^10*, Andreas Viardot, MD PhD¹¹, William Townsend, MD, FRCPath, MRCP^12*, Naseer Qayum, MD PhD^13*, Martin Barrett, PhD^13*, Derrick Kaufman, PhD^14*, Chun Wu, PharmD^15*, Ronald McCord, PhD^14*, Pauline Baumlin, PharmD^16*, Patrick Kimes, PhD^14* and Franck Morschhauser, MD PhD¹⁷

¹Universitätsklinikum Würzburg, Würzburg, Germany
²Ospedale Santa Maria delle Croci, Ravenna, Italy
³The Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia
⁴Levine Cancer Institute/Atrium Health, Charlotte, NC
⁵Humanitas University and IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy
⁶Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Naples, Italy
⁷Department of Hematology, Vall d' Hebron University Hospital, Barcelona, Spain
⁸School of Medicine, University of Nottingham, Nottingham, United Kingdom
⁹Hospital Clínic de Barcelona, Barcelona, Spain
¹⁰CHU de Nantes, Nantes, France
¹¹University Hospital Ulm, Ulm, Germany
¹²NIHR Clinical Research Facility, University College Hospitals London, London, United Kingdom
¹³Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁴Genentech, Inc., South San Francisco, CA
¹⁵Roche (China) Holding Ltd, Shanghai, China
¹⁶F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁷University of Lille, CHU Lille, Lille, France

Liqin Ping^1*, Xiaoxiao Wang^1*, Yan Gao^1*, Bing Bai^1*, He Huang^2*, Linbo Cai^3*, Hui Zhou⁴, Changguo Shan^3*, Zhiming Li^1*, Mingyao Lai^3*, Haixia He^2*, Cheng Huang^1*, Haoqing Chen^1*, Ru Feng^5* and Huiqiang Huang, MD, PhD²

¹Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
²Sun Yat-Sen University Cancer Center, Guangzhou, China
³Guangdong Sanjiu Brain Hospital, guangzhou, China
⁴Hunan Cancer Hospital, Changsha, China
⁵Nanfang Hospital, Southern Medical University, Guangzhou, China

Brian T. Hill, MD¹, Pallawi Torka², Francisco J. Hernandez-Ilizaliturri, MD³, Robert M. Dean, MD⁴, Deepa Jagadeesh, MD¹, Kasra Karamlou, MD¹, Chieh-Lin Fu, MD⁵, Allison Winter, MD⁴, Ethan Krauspe, MD^1*, Jonathan Zhou, BS^1*, Taylor R. Brooks, MD^1*, Merve Kacar^6*, Ben K. Tomlinson, MD⁷, Brenda W Cooper, MD⁷, Hong Li, MS^8*, Xuefei Jia, MS^1*, Yanwen Chen, PhD^1*, Jenna Thomas, PharmD^1* and Paolo F. Caimi, MD⁴

¹Cleveland Clinic, Cleveland, OH
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, Montvale, NJ
³Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁵Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL
⁶Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁷University Hospitals Seidman Cancer Center, Cleveland, OH
⁸Department of Biostatistics and Quantitative Health Sciences, Cleveland Clinic, Cleveland

Gulrayz Ahmed, MD, FACP¹, Aseel Alsouqi, MD^2*, Aniko Szabo, PhD^1*, Alexandra E. Rojek, MD³, Peter A. Riedell, MD⁴, Farrukh T. Awan, MD⁵, Laura Samples, MD⁶, Mazyar Shadman, MD, MPH⁷, Marie Hu, MD⁸, Veronika Bachanova, MD, PhD⁸, William Wesson, MPH⁹, Nausheen Ahmed, MD¹⁰, Madiha Iqbal, MD¹¹, Mohamed A. Kharfan-Dabaja, MD, MBA¹², Michael Scordo¹³, Patrick Connor Johnson, MD¹⁴, Yi-Bin Chen, MD, MS¹⁵, Sawa Ito, MD¹⁶, Mehdi Hamadani, MD¹⁷ and Matthew J. Frigault, MD, MS¹⁸

¹Medical College of Wisconsin, Milwaukee, WI
²University of Pittsburgh Medical Center, Pittsburgh, PA
³Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁴David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
⁵Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁶Fred Hutchinson Cancer Center and University of Washington School of Medicine, Seattle, WA
⁷Fred Hutchinson Cancer Center, Seattle, WA
⁸Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
⁹University of Kansas School of Medicine, Kansas City, KS
¹⁰University of Kansas Cancer Center, Westwood, KS
¹¹Mayo Clinic Florida, Jacksonville, FL
¹²Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
¹³Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Cancer Center, Massachusetts General Hospital, Boston, MA
¹⁵Massachusetts General Hospital, Boston, MA
¹⁶Hematology and Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
¹⁷Division of Hematology and Oncology, The Medical College of Wisconsin Inc, Milwaukee, WI
¹⁸Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA

Jun Zhu, PhD¹, Yuqin Song, MD², Ye Guo^3*, Keshu Zhou, MD^4*, Wenyu Li^5*, Yu Yang^6*, Qingqing Cai, PhD^7*, Zhao Wang, MD, PhD⁸ and Haiyan Yang, PhD⁹

¹Peking University Cancer Hospital, Beijing, China
²Peking University Cancer Hospital and Institute, Beijing, China
³Shanghai East Hospital, Shanghai, China
⁴Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁵Guangdong Provincial People's Hospital, Guangzhou, China
⁶Fujian Provincial Cancer Hospital, The Affiliated Tumor Hospital of Fujian Medical University, Fuzhou, China
⁷Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
⁸Beijing Friendship Hospital,Capital Medical University, Beijing, China, Beijing, China
⁹Zhejiang Cancer Hospital, Hangzhou, Zhejiang

A. De Jonge^1,2*, Marie José Kersten, MD, PhD^1,3, Erik van Werkhoven, MSc^4,5*, Marjolein van der Poel, MD PhD^6*, Koen de Heer, MD^7*, Clara Klerk, MD PhD^8*, Yorick Sandberg, MD PhD^9*, Rozemarijn S Van Rijn, MD, PhD^10*, Rob Fijnheer, MD PhD^11*, Pim Mutsaers, MD^12*, Vibeke Vergote, MD^13*, Djamila Issa, MD PhD^14*, Aart Beeker, MD¹⁵, Yavuz M. Bilgin, MD PhD^16*, Lara H. Böhmer, MD^17*, Laurens Nieuwenhuizen, MD PhD^18*, Wendy Stevens, MD^19*, Roel JW van Kampen, MD PhD²⁰, Rogier Mous, MD PhD^21*, Marc Durian, MD^22*, Tjeerd Snijders, MD^23*, Joost S.P Vermaat, MD, PhD, MSc²⁴, Otto Visser, MD PhD^25*, Josée M. Zijlstra, MD, PhD^26,27, Henk Hofwegen^5*, Helma G.J.M. Zanders^5*, Liping P. Fu^28*, Daphne De Jong, MD PhD^29*, Marcel Nijland, MD PhD^30* and Martine E.D. Chamuleau, MD PhD^1,2

¹Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands
²Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
³Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
⁴Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands
⁵HOVON foundation, Rotterdam, Netherlands
⁶Department of Internal Medicine, Division of Hematology, Maastricht University Medical Center, Maastricht, Netherlands
⁷Department of Internal Medicine, Flevoziekenhuis, Almere, Netherlands
⁸Department of Internal Medicine, Dijklanderziekenhuis, Hoorn, NLD
⁹Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands
¹⁰Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands
¹¹Department of Internal Medicine, Meander Medisch Centrum, Amersfoort, Netherlands
¹²Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹³Department of Hematology, University Hospitals Leuven, Leuven, BEL
¹⁴Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, Netherlands
¹⁵Spaarne Ziekenhuis, Hoofddorp, Netherlands
¹⁶Department of Internal Medicine, Adrz, Goes, Netherlands
¹⁷Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
¹⁸Department of Internal Medicine, Máxima Medisch Centrum, Eindhoven, Netherlands
¹⁹Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
²⁰Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, Netherlands
²¹Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
²²Department of Internal medicine, Elisabeth-TweeSteden Ziekenhuis, Tilburg, NLD
²³Department of Internal medicine, Medisch Spectrum Twente, Enschede, Netherlands
²⁴Leiden University Medical Center, Leiden, Netherlands
²⁵Department of Hematology, Isala Hospital, Zwolle, Netherlands
²⁶Cancer Center Amsterdam, Imaging, Amsterdam, Netherlands
²⁷Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²⁸Department of Pathology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²⁹Department of Pathology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, Netherlands
³⁰Department of Hematology, University Medical Center Groningen, Groningen, Netherlands

Yige Shen^1*, Yiwen Cao^2*, Shu Cheng^3*, Pengpeng Xu^3*, Li Wang^4* and Weili Zhao³

¹National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
²Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, CHN
³Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁴Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, shanghai, China

Joshua Brody, MD^1*, Judit Mészáros Joergensen, MD, PhD^2*, David Belada, MD^3*, Regis T. Costello, MD, PhD^4*, Marek Trněný, MD⁵, Umberto Vitolo, MD⁶, David Lewis, MBChB, PHD^7*, Yasmin H. Karimi, MD⁸, Anna Maria Sureda Balari, MD, PhD⁹, Marc André, MD, PhD^10*, Björn E. Wahlin, MD, PhD¹¹, Pieternella Lugtenburg, MD, PhD¹², Faith Galderisi, DO¹³, Aqeel Abbas, MS^14*, Yaou Song, MS^14*, Malene Risum, MD, PhD^15* and Raul Cordoba, MD, PhD¹⁶

¹Icahn School of Medicine at Mount Sinai, New York, NY
²Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
³4th Department of Internal Medicine - Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic
⁴Assistance Publique – Hôpitaux de Marseille (AP-HM), Marseille, France
⁵First Department of Medicine, First Faculty of Medicine, Charles University General Hospital, Prague, Czech Republic
⁶Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy
⁷University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
⁸Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
⁹Institut Català d’Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
¹⁰CHU UCL Namur, Yvoir, Belgium
¹¹Karolinska Institutet, Stockholm, Sweden
¹²Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Rotterdam, Netherlands
¹³AbbVie, North Chicago, IL
¹⁴Genmab, Plainsboro, NJ
¹⁵Genmab, Copenhagen, Denmark
¹⁶Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain

Graham P. Collins, MBBS, DPhil^1,2, William Townsend, MD, FRCPath, MRCP^3*, Ahmed Abdulgawad^4*, Swathi Namburi⁵, Anja Williams^6*, Ana Filipa Palma DosReis^7*, Matthew G. Krebs^8*, Jeff Evans^9*, Sarah P. Blagden^10*, Ruth Plummer^11*, Daniel Hochhauser^3*, Adam Sharp^12*, George Cole^13*, Seema Rogers^13*, Daniel Chan^13*, Sarah Whelan^13* and Dima El-Sharkawi, MBBS, FRCPath, PhD^14*

¹Haematology, Oxford Cancer and Haematology Centre, Oxford, ENG, United Kingdom
²Department of Clinical Haematology, Oxford University Hospitals, Oxford, United Kingdom
³University College London (UCL), London, United Kingdom
⁴The Christie NHS Foundation Trust, Manchester, United Kingdom
⁵MultiCare Tacoma General Hospital, Seattle, WA
⁶Sarah Cannon Research Institute (SCRI), London, United Kingdom
⁷Cancer Research UK, Cambridge Centre & Department of Oncology, University of Cambridge & Addenbrooke’s Hospital, Cambridge, United Kingdom
⁸The Christie NHS Foundation Trust, University of Manchester, Manchester, United Kingdom
⁹University of Glasgow, Glasgow, United Kingdom
¹⁰University of Oxford, Oxford, United Kingdom
¹¹Northern Centre for Care, Newcastle upon Tyne, United Kingdom
¹²The Institute of Cancer Research, and the Royal Marsden Hospital, London, United Kingdom
¹³Nurix Therapeutics, Inc., San Francisco, CA
¹⁴The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Benoit Tessoulin^1,2*, Julien Depaus, MD^3*, Pierre Feugier^4*, Ludovic Fouillet^5*, Julie Abraham^6*, Sandy Amorin^7*, Fabrice Jardin, MD PhD^8*, Franck Morschhauser, phd⁹, Catherine Thieblemont, MD^10*, François-Xavier Gros^11*, Bertrand Joly, MD^12*, Hacene Zerazhi, MD^13*, Sophie Bernard^14*, Adrien Chauchet^15*, Stéphane Vigouroux^16*, Christophe Bonnet, MD, PhD^17*, Sarah Bailly^18* and Steven Le Gouill, MD, PhD¹⁹

¹CRCI2NA, Integrated Research Center in Immunology and Oncology, Nantes University, Nantes, France
²Hematology Department, CHU Nantes, Nantes, France
³Hematologie, CHU UCL Namur, Yvoir, BEL
⁴Henri Poincaré University, Vandoeuvre Les Nancy, FRA
⁵Hematologie, CHU Saint Etienne, St Priest En Jarez Cedex, FRA
⁶CHU DE LIMOGES - HÔPITAL UNIVERSITAIRE DUPUYTREN, Limoges, FRA
⁷Hematology, Hôpital Saint Vincent-De-Paul, LILLE, FRA
⁸Centre Henri-Becquerel and University of Rouen, Rouen, France
⁹Hôpital Claude Huriez, Lille, France
¹⁰Hopital Saint-Louis, Paris, France
¹¹Hôpital Du Haut-Lévèque, CHU de Bordeaux, Pessac, FRA
¹²Hematology department, Centre Hospitalier Francilien Sud, Corbeil-Essonne, France
¹³Oncologie Médicale et Hématologie clinique, CH d'Avignon - Hôpital Henri Duffaut, Avignon, France
¹⁴Service Hématologie, Centre hospitaliser de la côte basque, Bayonne, France
¹⁵Besançon University Hospital, Besançon, France
¹⁶Centre Hospitalier Départemental - Service d'Onco-Hématologie, La Roche Sur Yon Cedex 9, FRA
¹⁷Hematology Department, CHU Liège, Liège, Belgium
¹⁸Cliniques Universitaires Saint Luc, Brussels, BEL
¹⁹Hematology Department, Institut Curie, Paris, France

Sarit Assouline, MD¹, Katharine L. Lewis², Rosemary Anne Harrup^3*, Robert J Lutz, PhD^4*, Jenny Thirlway, PhD^4*, Jutta Deckert, PhD⁴, David M Browning^4*, Debra L Wood, MD^4*, Paul I. Nadler, MD^4* and Seung Tae Lee, MD⁵

¹Jewish General Hospital, Montreal, QC, Canada
²Sir Charles Gairdner Hospital, Nedlands, Australia
³Royal Hobart Hospital, Tasmania, Australia
⁴Iksuda Therapeutics Ltd, Newcastle-upon-Tyne, United Kingdom
⁵University of Maryland, Baltimore, MD

Birgit Burkhardt, MD PhD^1*, Gianluca Rossato, PhD^2*, Mark Dixon, MSc BSc^3*, David John Carlile, PhD BSc^3*, Steven Dmytrasz, BSc^4*, Jade Wulff, MD^5*, Raluca Negricea, MPharm^3* and Beate Wulff, MD²

¹Department of Pediatric Hematology, Oncology and BMT, University Hospital Muenster, Muenster, Germany
²F. Hoffmann-La Roche Ltd, Basel, Switzerland
³Roche Products Ltd, Welwyn Garden City, United Kingdom
⁴Hoffmann-La Roche Ltd, Mississauga, ON, Canada
⁵Genentech, Inc., South San Francisco, CA

Emma Seaford^1*, Shanna Maycock, MSc^2*, Sarah Alexander, MD^3*, Auke Beishuizen, MD, PhD⁴, Birte Wistinghausen, MD⁵, Veronique Minard-Colin, MD, PhD^6*, Charlotte Rigaud, MD^6*, Charles A Phillips, MD^7*, James B. Ford, DO⁸, Pamela R. Kearns, PhD, FRCPC^2*, Anna Lawson, BSc^2*, Ellie Williams^9*, Zahra Ahmed^2*, Mahnoor Muzaffar^2*, Rhianna Parsons^2*, Lia Gore, MD^10,11, Nicole Scobie^12*, Victoria Buenger^13*, Carl Allen^14*, Karin Mellgren^15*, Catherine M. Bollard, MD⁵, Anne Auperin^6*, Lucinda Billingham^2* and Gladstone Austin Amos Burke, MB, PhD^16*

¹University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
²Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
³The Hospital For Sick Children, Toronto, ON, CAN
⁴Princess Máxima Center For Pediatric Oncology, Utrecht, NLD
⁵Children’s National Hospital, Washington, DC
⁶Gustave Roussy, Villejuif, France
⁷Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
⁸University of Nebraska Medical Center, Omaha, NE
⁹Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, ENG, United Kingdom
¹⁰Children's Hospital Colorado, Aurora, CO
¹¹Center for Cancer and Blood Disorders, University of Colorado Cancer Center, Aurora, CO
¹²Zoé4life, Sullens, Switzerland
¹³Coalition Against Cancer, Philadelphia, PA
¹⁴Texas Children's Cancer Center, Houston, TX
¹⁵Queen Silvia Children’s Hospital, Gothenburg, SWE
¹⁶Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Ajlan Al Zaki, MD, PhD¹, Lei Feng, MS^2*, Jason Westin, MD^3,4, Ranjit Nair, MD⁵, Luis Fayad, MD⁶, Grace Watson^7*, Sherry Adkins, ANP^8*, Elizabeth J. Shpall, MD⁹, Mario L. Marques-Piubelli, MD¹⁰, Jared Henderson^11*, Loretta J. Nastoupil, MD⁸, Christopher R. Flowers, MD, MS¹², Sairah Ahmed, MD¹³, Sattva S. Neelapu, MD¹² and Paolo Strati, MD¹²

¹Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
²Biostatistics, UT MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma & Myeloma, M.D. Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
⁶Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX
⁷MD Anderson Cancer Center:, Houston, TX
⁸MD Anderson Cancer Center, Houston, TX
⁹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX

Irit Avivi Mazza, MD^1*, Pere Barba, MD², Junichiro Yuda, MD, PhD³, Maria Lia Palomba, MD⁴, Juan Pablo Alderuccio, MD⁵, Ciel De Vriendt^6*, Paolo Corradini, MD⁷, Francesca Lorraine Wei Inng Lim^8*, Pier Luigi Zinzani, MD, PhD⁹, Nitin Jain, MD¹⁰, Jessica T. Leonard, MD¹¹, Michelle Coulson^12*, Nadia Hassounah^12*, Xiaoling Yang^12*, Haihui Lu^12*, Andrew Lewandowski^12*, Joseph Ryan Polli^12*, Matthieu Klopfenstein^13*, Alessandro Pastore, MD¹³ and Gabriel Brisou^14*

¹BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Deparment of Hematology, Vall Hebron Institute of Oncology (VHIO), Hospital Universitari Vall D'Hebron, La Garriga, Barcelona, Spain
³National Cancer Center Hospital East, Kashiwa, Japan
⁴Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁶University Hospital Ghent: Universitair Ziekenhuis, Gent, BEL
⁷University of Milan and Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
⁸Department of Hematology, Singapore General Hospital, Singapore, Singapore
⁹Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
¹⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR
¹²Novartis Institutes for BioMedical Research, Cambridge, MA
¹³Novartis Institutes for BioMedical Research, Basel, Switzerland
¹⁴Department of Hematology, Institut Paoli-Calmettes, Marseille, France

Cecilia Carpio^1*, Manjusha Namuduri^2*, Nazia Iqbal^2*, Dishan Liu^2*, Nickolas Sophos^2*, Min Zhu^2*, Ayesha Sabir^2*, Jurriaan Brouwer-Visser^2*, Aafia Chaudhry², Hesham Mohamed² and Alejandro Martín García-Sancho^3*

¹Department of Hematology, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain
²Regeneron Pharmaceuticals, Inc., Tarrytown, NY
³Department of Hematology, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain

Andrew L. Sochacki^1*, Jan A. Burger, MD, PhD ², Carrianne Ludwig^3*, Wissam Assaily, PhD^3*, Wijith Munasinghe^3*, William Pappano^3*, Edward Greenberg^3*, Christine Will, MS^3* and Meghan C. Thompson, MD⁴

¹START Midwest, Grand Rapids, MI
²Department of Leukemia, MD Anderson Cancer Center, Houston, TX
³AbbVie Inc., North Chicago, IL
⁴Memorial Sloan Kettering Cancer Center, New York, NY

Adam Olszewski, MD^1*, David Kahn^2*, Brian Yoo^3*, Joanne BL Tan³, Vipul K Gupta^3*, Edgar Schuck^3*, Zhe Nie^3*, Goran Krilov^3*, D. Hamish Wright³, Daniel Weiss^3*, Jean Lachowicz^3*, Karen Akinsanya^3* and Wu Yin, PhD³

¹Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence, Providence, RI
²NAPA Research, Pompano Beach, FL
³Schrödinger, Inc., New York, NY

Katharine L. Lewis^1,2,3, Piers Blombery, MBBS^4,5,6, Nagendra Prasad Sungala, MBBS⁷, Chun Kei Kris Ma, BSc MBBS PhD FRACP FRCPA^8,9, Pratyush Giri, MBBS^10*, Vinay Vanguru, MBBS, FRACP, FRCPA^11*, Tara Cochrane, MBBS, FRCPA, FRACP¹², Joanna Katarzyna Czerwinski, MD, BSc, FRACP, FRCPA¹³, Denise Lee, MBBS, FRCPA, FRACP^14*, Nada Hamad, BSc MSc MBBS FRACP FRCPA^15,16, Roslyn Francis, MBBS, FRACP, PhD^17,18*, Mannu Walia, PhD^19*, Julia Carlson, Bsc^19*, Belinda E Butcher, PhD^20* and Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc^1,21,22,23

¹Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
²Sir Charles Gairdner Hospital, Nedlands, Australia
³Sir Charles Gairdner Hospital, West Leederville, Australia
⁴Peter Maccallum Cancer Centre, East Melbourne, VIC, Australia
⁵Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia
⁶Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁷Liverpool Hospital, Liverpool, NSW, AUS
⁸The University of Sydney, Camperdown, Australia
⁹Westmead Hospital, Westmead, NSW, Australia
¹⁰Royal Adelaide Hospital, Adelaide, Australia
¹¹Institute of Haematology, Royal Prince Alfred Hospital, NSW, Australia
¹²Department of Haematology, Gold Coast University Hospital, Southport, Australia
¹³Flinders Medical Centre, Bedford Park, AUS
¹⁴Eastern Health Clinical School, Monash University, Eastern Health, Box Hill, Australia
¹⁵Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
¹⁶The University of New South Wales, Kensington, NSW, Australia
¹⁷Dept of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Australia
¹⁸Medical School, University of Western Australia, Perth, Australia
¹⁹Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
²⁰WriteSource Medical Pty Ltd, Lane Cove, NSW, Australia, Lane Cove, Australia
²¹Medical School, University of Western Australia, Crawley, Western Australia, Australia
²²Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
²³Department of Haematology, Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine, Nedlands, Western Australia, Australia

Michael P Randall, MD¹, Andreas Rauschecker, M.D., Ph.D.^2*, Liam Gima-Lange, B.S.^1*, Jenai Wilmoth, RN^1*, Lingjing Chen^1*, Ming Lu^1*, Huimin Geng, PhD^3*, Haifaa Abdulhaq, MD^4,5 and James L. Rubenstein, MD, PhD⁶

¹Hematology/Oncology Department of Medicine, University of California, San Francisco, San Francisco, CA
²Radiology and Biomedical Imaging, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
³Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
⁴University of California San Francisco, Fresno/Community Cancer Institute, Clovis, CA
⁵Hematology/Oncology, University of California, San Francisco, Fresno, CA
⁶Hematology/Oncology Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA